Skip to content
WeighLab
Menu
Ranked #102 · Grade C

Ivy Rx review

Ivy Rx (Ivy RX PLLC) sells compounded semaglutide from $77/mo (microdose) or $97/mo (standard, shown as a discount from a $197 struck-through price the site doesn't explain).

Visit Ivy Rx Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$97/mo (microdose tier, promotional rate, compounded)
Tirzepatide
$199/mo (brand Mounjaro, compounded)
Coverage
All 50 states
Brand-name
Yes

Semaglutide · modeled / year

$1,164

Tirzepatide · modeled / year

$2,388

Pricing verified August 2026

The Index scorecard

Ivy Rx scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month47/100
Price Transparency78/100
Nationwide Access86/100
Formulation Options79/100
Clinical Oversight82/100
Contract Flexibility47/100

Where the value is

  • Genuinely low entry price on the semaglutide microdose tier ($77/mo)
  • HSA/FSA eligible with itemized receipts for reimbursement
  • Legal entity is named (Ivy RX PLLC), which many competitors in this batch do not disclose
  • Free/discreet delivery advertised with no separate shipping fee mentioned

The tradeoffs

  • The standard semaglutide price is shown as a struck-through discount ('$197 $97') with no label clarifying whether $97 is a standing rate or a temporary promo
  • The advertised $199/mo tirzepatide rate requires a 12-month upfront lump-sum payment, not month-to-month billing, and a separate unexplained $1,399 vial price appears on the same page
  • No state-coverage list published anywhere on the site
  • No named medical director, prescriber, or specific compounding pharmacy

The bottom line

Best for: Cost-first shoppers who want the lowest published entry price on a semaglutide microdose, for shoppers comfortable with unresolved pricing terms. Ivy Rx (Ivy RX PLLC) sells compounded semaglutide from $77/mo (microdose) or $97/mo (standard, shown as a discount from a $197 struck-through price the site doesn't explain).

Ranked #102 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Ivy Rx.

The 18 programs nearest this one

Pricing, states and verification reflect Ivy Rx's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Ivy Rx's site. Not medical advice; see our disclosure.

← Back to the value leaderboard